Lanadelumab improves health-related quality of life in patients with hereditary Angioedema (HAE): findings from the HELP study

被引：0
|
作者：
Longhurst, Hilary [1 ]
Lumry, William [2 ]
Weller, Karsten [3 ]
Magerl, Markus [3 ]
Lu, Peng [4 ]
Jain, Gagan [4 ]
Lewis, Hannah [5 ]
Maurer, Marcus [3 ]
机构：
[1] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Cambridge, England
[2] Allergy & Asthma Res Associates Res Ctr, Dallas, TX USA
[3] Charite Univ Med Berlin, Dept Dermatol & Allergy, Berlin, Germany
[4] Shire, Lexington, MA USA
[5] ICON Plc, London, England
来源：
CLINICAL AND EXPERIMENTAL ALLERGY | 2018年 / 48卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
OP.019
引用
收藏
页码：1524 / 1525
页数：2
相关论文
共 50 条
  • [31] Health-related quality of life and its risk factors in Chinese hereditary angioedema patients
    Shuang Liu
    Xue Wang
    Yingyang Xu
    Qun Xu
    Yuxiang Zhi
    Orphanet Journal of Rare Diseases, 14
  • [32] Increased Response to Higher Dose Lanadelumab in Hereditary Angioedema Patients: Exploratory Findings From the HELP and HELP OLE Studies
    Jacobs, Joshua S.
    Bernstein, Jonathan
    Davis-Lorton, Mark
    Li, H. Henry
    Soteres, Daniel F.
    Nurse, Christina
    Paes, Kim
    Sexton, Daniel J.
    Longhurst, Hilary
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB39 - AB39
  • [33] Hereditary angioedema: health-related quality of life in Canadian patients as measured by the SF-36
    Jindal, Nina Lakhani
    Harniman, Elaine
    Prior, Nieves
    Perez-Fernandez, Elia
    Caballero, Teresa
    Betschel, Stephen
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2017, 13
  • [34] Hereditary angioedema: health-related quality of life in Canadian patients as measured by the SF-36
    Nina Lakhani Jindal
    Elaine Harniman
    Nieves Prior
    Elia Perez-Fernandez
    Teresa Caballero
    Stephen Betschel
    Allergy, Asthma & Clinical Immunology, 13
  • [35] Development of a health-related quality of life instrument for patients with hereditary angioedema living in the United States
    Busse, Paula J.
    Christiansen, Sandra C.
    Birmingham, Janette M.
    Overbey, Jessica R.
    Banerji, Aleena
    Otani, Iris M.
    Lumry, William
    Goryachkovsky, Anna
    Zuraw, Bruce L.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (05): : 1679 - +
  • [36] LANADELUMAB FOR PREVENTION OF ATTACKS IN HEREDITARY ANGIOEDEMA: RESULTS FROM THE PHASE 3 HELP STUDY
    Banerji, A.
    Riedl, M.
    Bernstein, J.
    Cicardi, M.
    Longhurst, H.
    Zuraw, B.
    Maurer, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S5 - S5
  • [37] Effectiveness of lanadelumab for preventing hereditary angioedema attacks: Subgroup analyses from the HELP study
    Johnston, Douglas T.
    Busse, Paula J.
    Riedl, Marc A.
    Maurer, Marcus
    Anderson, John
    Nurse, Christina
    Inhaber, Neil
    Yu, Ming
    Banerji, Aleena
    CLINICAL AND EXPERIMENTAL ALLERGY, 2021, 51 (10): : 1391 - 1395
  • [38] Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema (HAE) attacks in the phase 3 HELP study: Findings for days 0-69 and at steady state
    Maurer, M.
    Riedl, M. A.
    Bernstein, J. A.
    Banerji, A.
    Longhurst, H. J.
    Li, H. H.
    Lu, P.
    Hao, J.
    Juethner, S.
    Lumry, W. R.
    ALLERGY, 2019, 74 : 209 - 209
  • [39] Quality of life during lanadelumab treatment in patients with hereditary angioedema: 24-month results from the enable study
    Saguer, I. Martinez
    Magerl, M.
    Andriotti, T.
    Botha, J.
    Agmon-Levin, N.
    Watt, M.
    Maurer, M.
    ALLERGY, 2023, 78 : 26 - 27
  • [40] Lanadelumab for prevention of attacks in hereditary angioedema: results from the Phase 3 HELP Study
    Banerji, A.
    Riedl, M. A.
    Bernstein, J. A.
    Cicardi, M.
    Longhurst, H. J.
    Zuraw, B. L.
    Bruelle, J.
    Maurer, M.
    SWISS MEDICAL WEEKLY, 2018, 148 : 28S - 29S
12345